Filing Flows › Syra Health (SYRA) › R&D spending
Syra Health (SYRA) R&D spending by quarter
Syra Health's R&D spending was $47K in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 7 quarters it ranged from $139 (Q4 2025) to $47K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $47K | -1% | 57× |
| Q2 2026 | $47K | +584% | +59% |
| Q1 2026 | $7K | 50× | -81% |
| Q4 2025 | $139 | -83% | — |
| Q3 2025 | $1K | -97% | — |
| Q2 2025 | $30K | -20% | — |
| Q1 2025 | $37K | — | — |
Q3 2026 at a glance
Syra Health, Q3 2026: revenue $2.6M (+52% year over year), operating margin 11.7%, net earnings $345K, operating cash flow $332K. The chart follows the revenue to costs, profit and cash.
Questions
What is Syra Health's R&D spending?
Syra Health's R&D spending was $47K in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Syra Health's R&D spending changed?
Over the last 7 quarters it ranged from $139 (Q4 2025) to $47K (Q2 2026).